nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiludronate—PTPN1—embryo—colon cancer	0.0506	0.136	CbGeAlD
Tiludronate—PTPN1—renal system—colon cancer	0.0383	0.103	CbGeAlD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—PTPRJ—colon cancer	0.0358	0.0762	CbGpPWpGaD
Tiludronate—PTPN1—lymphoid tissue—colon cancer	0.0318	0.0857	CbGeAlD
Tiludronate—PTPN1—digestive system—colon cancer	0.0314	0.0847	CbGeAlD
Tiludronate—ATP6V1A—embryo—colon cancer	0.0303	0.0817	CbGeAlD
Tiludronate—PTPN1—vagina—colon cancer	0.0277	0.0748	CbGeAlD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—PTPRJ—colon cancer	0.025	0.0533	CbGpPWpGaD
Tiludronate—PTPN1—liver—colon cancer	0.0234	0.0631	CbGeAlD
Tiludronate—ATP6V1A—renal system—colon cancer	0.0229	0.0618	CbGeAlD
Tiludronate—ATP6V1A—lymphoid tissue—colon cancer	0.019	0.0513	CbGeAlD
Tiludronate—ATP6V1A—digestive system—colon cancer	0.0188	0.0507	CbGeAlD
Tiludronate—PTPN1—lymph node—colon cancer	0.0179	0.0484	CbGeAlD
Tiludronate—ATP6V1A—bone marrow—colon cancer	0.0173	0.0468	CbGeAlD
Tiludronate—ATP6V1A—vagina—colon cancer	0.0166	0.0448	CbGeAlD
Tiludronate—Developmental delay—Fluorouracil—colon cancer	0.0154	0.096	CcSEcCtD
Tiludronate—Congenital anomaly—Fluorouracil—colon cancer	0.0154	0.096	CcSEcCtD
Tiludronate—ATP6V1A—liver—colon cancer	0.014	0.0378	CbGeAlD
Tiludronate—PTPN1—Integrin alphaIIb beta3 signaling—SRC—colon cancer	0.011	0.0235	CbGpPWpGaD
Tiludronate—ATP6V1A—lymph node—colon cancer	0.0107	0.029	CbGeAlD
Tiludronate—Congenital anomaly—Capecitabine—colon cancer	0.0107	0.0671	CcSEcCtD
Tiludronate—Developmental delay—Capecitabine—colon cancer	0.0107	0.0671	CcSEcCtD
Tiludronate—PTPN1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—colon cancer	0.0106	0.0226	CbGpPWpGaD
Tiludronate—PTPN1—Posttranslational regulation of adherens junction stability and dissassembly—CDH1—colon cancer	0.0104	0.0222	CbGpPWpGaD
Tiludronate—PTPN1—Leptin signaling pathway—BAX—colon cancer	0.0104	0.0222	CbGpPWpGaD
Tiludronate—PTPN1—N-cadherin signaling events—CTNNB1—colon cancer	0.00969	0.0207	CbGpPWpGaD
Tiludronate—PTPN1—Leptin signaling pathway—BCL2L1—colon cancer	0.00904	0.0193	CbGpPWpGaD
Tiludronate—PTPN1—Platelet Aggregation (Plug Formation)—SRC—colon cancer	0.00857	0.0183	CbGpPWpGaD
Tiludronate—PTPN1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—colon cancer	0.00833	0.0178	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by TCPTP—SRC—colon cancer	0.00805	0.0172	CbGpPWpGaD
Tiludronate—PTPN1—Posttranslational regulation of adherens junction stability and dissassembly—CASP3—colon cancer	0.00799	0.017	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by TCPTP—VEGFA—colon cancer	0.00784	0.0167	CbGpPWpGaD
Tiludronate—PTPN1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—colon cancer	0.00773	0.0165	CbGpPWpGaD
Tiludronate—PTPN1—IGF1 pathway—PIK3CA—colon cancer	0.00771	0.0164	CbGpPWpGaD
Tiludronate—PTPN1—Posttranslational regulation of adherens junction stability and dissassembly—CTNNB1—colon cancer	0.0077	0.0164	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—APC—colon cancer	0.00753	0.0161	CbGpPWpGaD
Tiludronate—PTPN1—IGF1 pathway—HRAS—colon cancer	0.00713	0.0152	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by TCPTP—EGFR—colon cancer	0.00706	0.015	CbGpPWpGaD
Tiludronate—PTPN1—Posttranslational regulation of adherens junction stability and dissassembly—SRC—colon cancer	0.00696	0.0148	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—CDH1—colon cancer	0.00693	0.0148	CbGpPWpGaD
Tiludronate—PTPN1—Integrin alphaIIb beta3 signaling—AKT1—colon cancer	0.00685	0.0146	CbGpPWpGaD
Tiludronate—PTPN1—N-cadherin signaling events—PIK3CA—colon cancer	0.00666	0.0142	CbGpPWpGaD
Tiludronate—Bone pain—Vincristine—colon cancer	0.00653	0.0409	CcSEcCtD
Tiludronate—PTPN1—Signaling events mediated by PTP1B—SRC—colon cancer	0.00653	0.0139	CbGpPWpGaD
Tiludronate—PTPN1—IGF1 pathway—AKT1—colon cancer	0.0063	0.0134	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by TCPTP—PIK3CA—colon cancer	0.00613	0.0131	CbGpPWpGaD
Tiludronate—PTPN1—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—colon cancer	0.0061	0.013	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—FGFR3—colon cancer	0.00609	0.013	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by PTP1B—EGFR—colon cancer	0.00572	0.0122	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Pathway—PIK3CA—colon cancer	0.00557	0.0119	CbGpPWpGaD
Tiludronate—PTPN1—Leptin signaling pathway—CCND1—colon cancer	0.00544	0.0116	CbGpPWpGaD
Tiludronate—PTPN1—Platelet Aggregation (Plug Formation)—AKT1—colon cancer	0.00533	0.0114	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Pathway—HRAS—colon cancer	0.00516	0.011	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—CTNNB1—colon cancer	0.00512	0.0109	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by PTP1B—PIK3CA—colon cancer	0.00497	0.0106	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—BRAF—colon cancer	0.00495	0.0106	CbGpPWpGaD
Tiludronate—PTPN1—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—colon cancer	0.0049	0.0104	CbGpPWpGaD
Tiludronate—PTPN1—Leptin signaling pathway—SRC—colon cancer	0.00487	0.0104	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—SRC—colon cancer	0.00463	0.00986	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Pathway—AKT1—colon cancer	0.00455	0.00971	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—LGR5—colon cancer	0.00438	0.00933	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CHST5—colon cancer	0.00438	0.00933	CbGpPWpGaD
Tiludronate—Bone pain—Capecitabine—colon cancer	0.00426	0.0266	CcSEcCtD
Tiludronate—PTPN1—Signaling events mediated by PTP1B—AKT1—colon cancer	0.00406	0.00865	CbGpPWpGaD
Tiludronate—Influenza like illness—Capecitabine—colon cancer	0.00396	0.0248	CcSEcCtD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—PIK3CA—colon cancer	0.00352	0.0075	CbGpPWpGaD
Tiludronate—PTPN1—Leptin signaling pathway—HRAS—colon cancer	0.00343	0.00731	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—NRAS—colon cancer	0.00331	0.00705	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—DLC1—colon cancer	0.00326	0.00695	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—DLC1—colon cancer	0.00326	0.00695	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—colon cancer	0.00326	0.00694	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—SRC—colon cancer	0.00324	0.0069	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—AXIN2—colon cancer	0.00314	0.0067	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—NRAS—colon cancer	0.00311	0.00664	CbGpPWpGaD
Tiludronate—Rhinitis—Irinotecan—colon cancer	0.00307	0.0192	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—LGR5—colon cancer	0.00306	0.00653	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—LGR5—colon cancer	0.00306	0.00653	CbGpPWpGaD
Tiludronate—PTPN1—Leptin signaling pathway—AKT1—colon cancer	0.00303	0.00645	CbGpPWpGaD
Tiludronate—Rhinitis—Fluorouracil—colon cancer	0.00294	0.0184	CcSEcCtD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—MYC—colon cancer	0.0029	0.00618	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—AKT1—colon cancer	0.00287	0.00613	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—KRAS—colon cancer	0.00284	0.00606	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—KRAS—colon cancer	0.00268	0.00571	CbGpPWpGaD
Tiludronate—Back pain—Vincristine—colon cancer	0.00265	0.0165	CcSEcCtD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—PIK3CA—colon cancer	0.00261	0.00557	CbGpPWpGaD
Tiludronate—Back pain—Irinotecan—colon cancer	0.00258	0.0161	CcSEcCtD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—PIK3CA—colon cancer	0.00246	0.00525	CbGpPWpGaD
Tiludronate—Vertigo—Vincristine—colon cancer	0.00246	0.0154	CcSEcCtD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—HRAS—colon cancer	0.00242	0.00515	CbGpPWpGaD
Tiludronate—Vertigo—Irinotecan—colon cancer	0.00239	0.015	CcSEcCtD
Tiludronate—Myalgia—Vincristine—colon cancer	0.00233	0.0146	CcSEcCtD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—HRAS—colon cancer	0.00228	0.00486	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—AXIN2—colon cancer	0.0022	0.00469	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—AXIN2—colon cancer	0.0022	0.00469	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—BCL10—colon cancer	0.00219	0.00468	CbGpPWpGaD
Tiludronate—Myalgia—Fluorouracil—colon cancer	0.00217	0.0136	CcSEcCtD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—ABCB1—colon cancer	0.00207	0.00441	CbGpPWpGaD
Tiludronate—Rhinitis—Capecitabine—colon cancer	0.00205	0.0128	CcSEcCtD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—SRC—colon cancer	0.00205	0.00437	CbGpPWpGaD
Tiludronate—Musculoskeletal discomfort—Vincristine—colon cancer	0.00203	0.0127	CcSEcCtD
Tiludronate—PTPN1—Insulin Signaling—PIK3CA—colon cancer	0.00202	0.00431	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—VEGFA—colon cancer	0.002	0.00426	CbGpPWpGaD
Tiludronate—Dyspepsia—Irinotecan—colon cancer	0.00191	0.012	CcSEcCtD
Tiludronate—Pain—Vincristine—colon cancer	0.00191	0.0119	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.0019	0.0119	CcSEcCtD
Tiludronate—PTPN1—Insulin Signaling—HRAS—colon cancer	0.00187	0.00399	CbGpPWpGaD
Tiludronate—Pain—Irinotecan—colon cancer	0.00186	0.0116	CcSEcCtD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—TGFB1—colon cancer	0.00183	0.00391	CbGpPWpGaD
Tiludronate—Dyspepsia—Fluorouracil—colon cancer	0.00183	0.0115	CcSEcCtD
Tiludronate—Gastrointestinal pain—Vincristine—colon cancer	0.00183	0.0114	CcSEcCtD
Tiludronate—Pain—Fluorouracil—colon cancer	0.00178	0.0111	CcSEcCtD
Tiludronate—Gastrointestinal pain—Irinotecan—colon cancer	0.00178	0.0111	CcSEcCtD
Tiludronate—Abdominal pain—Vincristine—colon cancer	0.00177	0.011	CcSEcCtD
Tiludronate—Back pain—Capecitabine—colon cancer	0.00173	0.0108	CcSEcCtD
Tiludronate—Abdominal pain—Irinotecan—colon cancer	0.00172	0.0107	CcSEcCtD
Tiludronate—PTPN1—Insulin Signaling—AKT1—colon cancer	0.00165	0.00352	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—NRAS—colon cancer	0.00163	0.00348	CbGpPWpGaD
Tiludronate—Vertigo—Capecitabine—colon cancer	0.0016	0.01	CcSEcCtD
Tiludronate—Asthenia—Vincristine—colon cancer	0.0016	0.01	CcSEcCtD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	0.00156	0.00333	CbGpPWpGaD
Tiludronate—Asthenia—Irinotecan—colon cancer	0.00156	0.00976	CcSEcCtD
Tiludronate—Diarrhoea—Vincristine—colon cancer	0.00153	0.00955	CcSEcCtD
Tiludronate—Myalgia—Capecitabine—colon cancer	0.00152	0.00949	CcSEcCtD
Tiludronate—Arthralgia—Capecitabine—colon cancer	0.00152	0.00949	CcSEcCtD
Tiludronate—Diarrhoea—Irinotecan—colon cancer	0.00149	0.0093	CcSEcCtD
Tiludronate—Dizziness—Vincristine—colon cancer	0.00148	0.00923	CcSEcCtD
Tiludronate—Dizziness—Irinotecan—colon cancer	0.00144	0.00899	CcSEcCtD
Tiludronate—Diarrhoea—Fluorouracil—colon cancer	0.00143	0.00891	CcSEcCtD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—KRAS—colon cancer	0.00141	0.003	CbGpPWpGaD
Tiludronate—Headache—Vincristine—colon cancer	0.0014	0.00875	CcSEcCtD
Tiludronate—Dizziness—Fluorouracil—colon cancer	0.00138	0.00861	CcSEcCtD
Tiludronate—Headache—Irinotecan—colon cancer	0.00136	0.00852	CcSEcCtD
Tiludronate—Nausea—Vincristine—colon cancer	0.00133	0.00829	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00133	0.00829	CcSEcCtD
Tiludronate—Headache—Fluorouracil—colon cancer	0.0013	0.00816	CcSEcCtD
Tiludronate—Nausea—Irinotecan—colon cancer	0.00129	0.00808	CcSEcCtD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—PIK3CA—colon cancer	0.00129	0.00275	CbGpPWpGaD
Tiludronate—Back pain—Methotrexate—colon cancer	0.00128	0.00803	CcSEcCtD
Tiludronate—Dyspepsia—Capecitabine—colon cancer	0.00128	0.00801	CcSEcCtD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—AKT1—colon cancer	0.00127	0.00272	CbGpPWpGaD
Tiludronate—Pain—Capecitabine—colon cancer	0.00124	0.00778	CcSEcCtD
Tiludronate—Nausea—Fluorouracil—colon cancer	0.00124	0.00774	CcSEcCtD
Tiludronate—PTPN1—Immune System—CD8A—colon cancer	0.0012	0.00256	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—HRAS—colon cancer	0.00119	0.00255	CbGpPWpGaD
Tiludronate—Vertigo—Methotrexate—colon cancer	0.00119	0.00746	CcSEcCtD
Tiludronate—Gastrointestinal pain—Capecitabine—colon cancer	0.00119	0.00744	CcSEcCtD
Tiludronate—Abdominal pain—Capecitabine—colon cancer	0.00115	0.00719	CcSEcCtD
Tiludronate—Arthralgia—Methotrexate—colon cancer	0.00113	0.00707	CcSEcCtD
Tiludronate—Myalgia—Methotrexate—colon cancer	0.00113	0.00707	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—EP300—colon cancer	0.00109	0.00232	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—SRC—colon cancer	0.00106	0.00225	CbGpPWpGaD
Tiludronate—Asthenia—Capecitabine—colon cancer	0.00104	0.00653	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—VEGFA—colon cancer	0.00103	0.0022	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—BCL2L1—colon cancer	0.00103	0.00219	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—NRAS—colon cancer	0.00102	0.00217	CbGpPWpGaD
Tiludronate—Diarrhoea—Capecitabine—colon cancer	0.000996	0.00623	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000987	0.00617	CcSEcCtD
Tiludronate—PTPN1—Immune System—FGFR3—colon cancer	0.000984	0.0021	CbGpPWpGaD
Tiludronate—Dizziness—Capecitabine—colon cancer	0.000963	0.00602	CcSEcCtD
Tiludronate—Dyspepsia—Methotrexate—colon cancer	0.000954	0.00596	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—TGFB1—colon cancer	0.000945	0.00201	CbGpPWpGaD
Tiludronate—Pain—Methotrexate—colon cancer	0.000927	0.00579	CcSEcCtD
Tiludronate—Headache—Capecitabine—colon cancer	0.000912	0.0057	CcSEcCtD
Tiludronate—ATP6V1A—Disease—FGFR3—colon cancer	0.000908	0.00194	CbGpPWpGaD
Tiludronate—Gastrointestinal pain—Methotrexate—colon cancer	0.000886	0.00554	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—KRAS—colon cancer	0.000876	0.00187	CbGpPWpGaD
Tiludronate—Nausea—Capecitabine—colon cancer	0.000865	0.00541	CcSEcCtD
Tiludronate—Abdominal pain—Methotrexate—colon cancer	0.000857	0.00536	CcSEcCtD
Tiludronate—ATP6V1A—Disease—APC—colon cancer	0.000834	0.00178	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CDH1—colon cancer	0.000831	0.00177	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PIK3CA—colon cancer	0.000804	0.00171	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—BRAF—colon cancer	0.000784	0.00167	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—TP53—colon cancer	0.000778	0.00166	CbGpPWpGaD
Tiludronate—Asthenia—Methotrexate—colon cancer	0.000777	0.00486	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—HRAS—colon cancer	0.000744	0.00159	CbGpPWpGaD
Tiludronate—Diarrhoea—Methotrexate—colon cancer	0.000741	0.00464	CcSEcCtD
Tiludronate—Dizziness—Methotrexate—colon cancer	0.000717	0.00448	CcSEcCtD
Tiludronate—Headache—Methotrexate—colon cancer	0.000679	0.00424	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—AKT1—colon cancer	0.000657	0.0014	CbGpPWpGaD
Tiludronate—Nausea—Methotrexate—colon cancer	0.000644	0.00402	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—FGFR3—colon cancer	0.000636	0.00136	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FGFR3—colon cancer	0.000636	0.00136	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PTGS2—colon cancer	0.000633	0.00135	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CTNNB1—colon cancer	0.000613	0.00131	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CDKN1A—colon cancer	0.000599	0.00128	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—APC—colon cancer	0.000584	0.00124	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—APC—colon cancer	0.000584	0.00124	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—EP300—colon cancer	0.00057	0.00122	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CTNNB1—colon cancer	0.000566	0.00121	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—SRC—colon cancer	0.000554	0.00118	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CDKN1A—colon cancer	0.000553	0.00118	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—BRAF—colon cancer	0.000549	0.00117	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—BRAF—colon cancer	0.000549	0.00117	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—NRAS—colon cancer	0.000533	0.00114	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—EP300—colon cancer	0.000526	0.00112	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—SRC—colon cancer	0.000512	0.00109	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—NRAS—colon cancer	0.000493	0.00105	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—EGFR—colon cancer	0.000486	0.00104	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—KRAS—colon cancer	0.000459	0.000979	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MYC—colon cancer	0.000459	0.000978	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—TGFB1—colon cancer	0.000458	0.000975	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—EGFR—colon cancer	0.000449	0.000956	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—KRAS—colon cancer	0.000424	0.000904	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PIK3CA—colon cancer	0.000422	0.000899	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CASP3—colon cancer	0.000411	0.000877	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CASP3—colon cancer	0.000411	0.000877	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CCND1—colon cancer	0.000401	0.000854	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CCND1—colon cancer	0.000401	0.000854	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CTNNB1—colon cancer	0.000397	0.000845	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CTNNB1—colon cancer	0.000397	0.000845	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—HRAS—colon cancer	0.00039	0.000832	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PIK3CA—colon cancer	0.000389	0.00083	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CDKN1A—colon cancer	0.000387	0.000826	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CDKN1A—colon cancer	0.000387	0.000826	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—EP300—colon cancer	0.000369	0.000786	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—EP300—colon cancer	0.000369	0.000786	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—HRAS—colon cancer	0.00036	0.000768	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SRC—colon cancer	0.000359	0.000764	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SRC—colon cancer	0.000359	0.000764	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—VEGFA—colon cancer	0.000349	0.000744	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—VEGFA—colon cancer	0.000349	0.000744	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NRAS—colon cancer	0.000345	0.000735	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NRAS—colon cancer	0.000345	0.000735	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—AKT1—colon cancer	0.000345	0.000734	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MYC—colon cancer	0.000321	0.000685	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MYC—colon cancer	0.000321	0.000685	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TGFB1—colon cancer	0.00032	0.000683	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TGFB1—colon cancer	0.00032	0.000683	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—AKT1—colon cancer	0.000318	0.000678	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—EGFR—colon cancer	0.000314	0.00067	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—EGFR—colon cancer	0.000314	0.00067	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—KRAS—colon cancer	0.000297	0.000633	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—KRAS—colon cancer	0.000297	0.000633	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PIK3CA—colon cancer	0.000273	0.000581	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PIK3CA—colon cancer	0.000273	0.000581	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TP53—colon cancer	0.000264	0.000562	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TP53—colon cancer	0.000264	0.000562	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HRAS—colon cancer	0.000252	0.000538	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HRAS—colon cancer	0.000252	0.000538	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—AKT1—colon cancer	0.000223	0.000475	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—AKT1—colon cancer	0.000223	0.000475	CbGpPWpGaD
